Biotech marketing agency: making your science readable, credible and compliant
Three audiences, two ways of being found, a tightening regulatory framework: how we make your innovation readable and credible.
You are developing a biotech or medtech innovation that holds up scientifically. That is not the problem. The problem is the gap between what your teams know and what your investors, your clinical partners or the generative engines understand when they search your category. DigiObs closes that gap, with one requirement: never betray rigor to gain clarity.
Contents
- A marketing agency designed for scientific companies, not adapted to them
- Science communication for a medtech startup: speaking to three audiences at once
- Biotech SEO in France and GEO: being found by Google and by generative engines
- Built-in compliance: AI Act, ANSM and CNIL from the first line
- What our clients see
- Going further
A marketing agency designed for scientific companies, not adapted to them
Most generalist agencies discover your sector at the same time as your brief. They produce smooth content that sounds good and says little, or worse, that simplifies to the point of becoming false. Among our biotech clients, this is complaint number one: a deliverable that no in-house scientist can validate without rewriting everything.
We start from the opposite. Rigorous science writing is our starting point, not a last-minute adjustment. Our content goes through reviewers who understand a mechanism of action, a clinical phase or a CE marking, and who know how to express uncertainty instead of erasing it. This requirement is not cosmetic. It is what makes a pitch credible in front of an investment committee, and what distinguishes the science communication of a medtech startup from mere marketing dressing.
Science communication for a medtech startup: speaking to three audiences at once
A medtech startup rarely speaks to a single audience. Investors want a trajectory and a market. Clinicians want data and clearly stated limits. Regulators want traceability. The same message cannot satisfy all three, and the classic mistake is to write for one while forgetting the other two.
We build a content architecture that adapts your science to each intent, without ever changing the underlying facts. The substance stays the same, the wording adjusts. In practice, this means an investor deck that embraces the narrative without overpromising, product sheets that hold up in front of regulatory affairs, and publications that feed your authority without exposing you. This consistency across registers is what protects your reputation when one audience comes across the messages meant for the others.
Biotech SEO in France and GEO: being found by Google and by generative engines
In France, competition on biotech queries remains low in volume but decisive in intent. Someone who types biotech marketing agency or medtech science communication is already far along in their thinking. Missing this handful of qualified visitors costs far more than missing generic traffic.
Our SEO work targets the industry long tail rather than saturated generic keywords, where your real expertise gives you a natural advantage. We add GEO, optimization for ChatGPT, Claude and Perplexity, which have become entry points where your future customers phrase their technical questions. A page well structured for these engines cites your data, attributes your sources and makes you a reference in the generated answers. It is ground that most French agencies have not yet covered, and where a few months' head start changes the game.
Built-in compliance: AI Act, ANSM and CNIL from the first line
Healthcare marketing operates in a tightening framework. Pharma campaigns have been suspended for CNIL non-compliance on tracking and consent. The AI Act now requires traceability for AI-assisted content. Many agencies discover these constraints after the fact, when the content is already online.
We treat compliance as a component of production, not as a box to tick at the end of the project. Every AI-assisted piece of content is documented with a usable audit trail, personalization respects the CNIL rules applicable to the healthcare sector, and product claims are calibrated to ANSM requirements. For a regulatory manager, this means less back and forth and controlled risk. For an executive, it means sleeping without fearing that a campaign becomes a liability.
What our clients see
“At last an agency that doesn’t need to be told what a phase II is. Internal reviews went from several cycles to near-direct validation.” (Chief Scientific Officer, medtech SME, diagnostic devices)
- On a six-month SEO and GEO engagement for a biotech startup raising funds, the average position on target industry queries moved into the top 5, and the optimized pages started being cited in Perplexity's answers for their category. Another client, a specialized laboratory, cut the production time of its regulatory sheets by three thanks to a content framework that is compliant from the writing stage.
- These figures remain modest in volume, as befits a niche sector. That is precisely the point: with such targeted audiences, the quality of a single lead matters more than the number of sessions.
Going further
Let's talk about your next deadline
A fundraising round to prepare, a launch to announce, a category where you want to become the reference that gets cited. Tell us where you stand, and we will tell you what is feasible and in what timeframe, with no commitment.
Frequently asked questions
Do your writers have real scientific training?
Yes. Our editorial chain relies on reviewers who come from research and can validate content on its substance. We document this expertise on request, with publications and career paths, because we know that the absence of verifiable scientific backing is a deal-breaker for you.
How does GEO differ from classic SEO?
SEO targets rankings in Google results. GEO optimizes the probability that your expertise is cited in the answers of generative engines such as ChatGPT or Perplexity. The two complement each other and we handle them together, because your customers already use both to inform themselves.
How do you guarantee AI Act and CNIL compliance?
Every AI-assisted piece of content comes with documented traceability. Tracking and personalization are configured according to the CNIL rules specific to the healthcare sector, and claims are checked against ANSM requirements before publication.
Are you accessible for an early-stage startup?
Our engagement formats are designed for organizations that do not have a full marketing team. We often start with a narrow scope, aligned with a concrete deadline such as a fundraising round or a launch, then broaden it according to your results.
How long before we see effects on visibility?
The first GEO signals often appear within a few weeks on niche queries with little competition. Google rankings and domain authority are built over several months. We set intermediate milestones so that you can measure progress without waiting for the end.
Do you work white-label or directly?
Both. Some in-house marketing teams bring us in to reinforce the technical content they cannot produce, others entrust us with the whole set-up. We adapt the way we work together to your existing organization.
What happens if a piece of content does not suit me?
Every deliverable goes through a validation cycle in which you keep the final say, including on scientific nuances. Our goal is precisely to reduce that back and forth by getting it right from the first version.
Let's talk about your project
Leading an innovative research project? Looking for a partner who can bring your idea to life beyond the scientific community?
Which type of engagement suits you best?